Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial - Concepedia

Concepedia

Publication | Closed Access

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

89

Citations

18

References

2024

Year

Nicoletta Colombo, Elena Biagioli, Kenichi Harano, Francesca Galli, Emma Hudson, Yoland Antill, Chel Hun Choi, Manuela Rabaglio, Frederic Marmé, Christian Marth,

The Lancet Oncology

Gynecological SurgeryMedicineMetronomic TherapyGynecologyRecurrent Endometrial CancerCancer TreatmentOncologyRadiation OncologyGynecology Oncology

References

	Year	Citations

Page 1

Page 1